C27H40O3

Vitamin D derivatives, combined with VD3 receptors on the cell surface, regulate the synthesis of DNA and keratin in cells, inhibit the excessive proliferation and induce the differentiation of skin cells (keratinocytes), so as to correct the abnormal proliferation and differentiation of psoriatic skin cells.

C27H44O2

Alfacalcidol is a vitamin D analog. It is important for the regulation of the bone metabolism. For the treatment of osteoporosis, vitamin D-dependent rickets and osteomalacia

C27H40O3

Calcipotriol is a topical vitaminD3 derivative effective in the treatment of psoriasis vulgaris. The drug acts by binding to vitamin D3 receptors in the skin keratinocytes, producing an elevation in cell differentiation and a reduction in cell proliferation.

C27H44O3

The biologically active form of vitamin D3. Calcium regulator; vitamin (antirachitic); antihyperparathyroid; antineoplastic; antipsoriatic

C27H44O2

A metabolite of Vitamin D. It is used to treat rickets and osteomalacia, both in azotemic and non-azotemic patient.

C28H44O2

Doxercalciferol is a synthetic vitamin D2 analog for the treatment of secondary hyperparathyroidism (SHPT) in patients with end-stage renal failure. It is actually 1-alpha-hydroxyvitamin D2 (one-alpha- D2) and can be synthesized by direct hydroxylation of vitamin D2 tosylate or in 5 steps from ergosterol.

C27H44O3

Synthetic analog of vitamin D. Antihyperparathyroid. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication.

C26H42O4

the third synthetic vitamin D analog, after paricalcitol and doxercalciferol, to be marketed for the treatment of secondary hyperparathyroidism (SHPT) associated with chronic renal failure.

C30H50O5

a vitamin D3 analog. a hormonally active calcitrol analog, regulates calcium and bone metabolism.

C27H44O3

Tacalcitol, the second vitamin D analog developed as a topical antipsoriatic, was introduced for keratosis, psoriasis, ichthyosis, pityriasis rubra pilaris and palmoplantar pustulosis and keratoderma.

C28H44O2

A metabolite of Vitamin D2

C30H46O3

A vitamin D analogue, acting on human osteosarcoma MG-63 cells, binds to vitamin D receptor protein with a KD of 0.27 nm.

C27H38F6O3

Hexafluorinated analog of Calcitriol (C144500). A more potent therapeutic agent for secondary hyperparathyroidism.

C8H12O6

Vitamin C derivative

C10H16N2O3S

It is a coenzyme of carboxylase, participates in many carboxylation reactions, and is an important coenzyme in the intermediate metabolism of sugar, protein and fat. It is used as a nutritional supplement